Health benefits of physical activity: the evidence
The primary purpose of this narrative review was to evaluate the current literature and to provide further insight into the role physical inactivity plays in the development of ...
Explore 3,177 academic publications
The primary purpose of this narrative review was to evaluate the current literature and to provide further insight into the role physical inactivity plays in the development of ...
Lies spread faster than the truth There is worldwide concern over false news and the possibility that it can influence political, economic, and social well-being. To understand ...
Despite an early loss of glycemic differences, a continued reduction in microvascular risk and emergent risk reductions for myocardial infarction and death from any cause were o...
We consider 27 population and community terms used frequently by parasitologists when describing the ecology of parasites. We provide suggestions for various terms in an attempt...
Atherosclerosis, formerly considered a bland lipid storage disease, actually involves an ongoing inflammatory response. Recent advances in basic science have established a funda...
1.0 INTRODUCTION Five practical issues become important in any analysis of drought. These include: 1) time scale, 2) probability, 3) precipitation deficit, 4) application of the...
These results demonstrate that the benefit of cholesterol-lowering therapy extends to the majority of patients with coronary disease who have average cholesterol levels.
Entropy, as it relates to dynamical systems, is the rate of information production. Methods for estimation of the entropy of a system represented by a time series are not, howev...
Four hundred M-mode echocardiographic surveys were distributed to determine interobserver variability in M-mode echocardiographic measurements. This was done with a view toward ...
Treatment with pravastatin significantly reduced the incidence of myocardial infarction and death from cardiovascular causes without adversely affecting the risk of death from n...
Background Canagliflozin is a sodium-glucose cotransporter 2 inhibitor that reduces glycemia as well as blood pressure, body weight, and albuminuria in people with diabetes. We ...